|
|||||
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each. This transaction highlights investor interest in the agrochemical firm. Mahamaya Lifesciences manufactures pesticide formulations and crop protection products. The company has shown strong financial growth recently. Its shares have performed well since their market debut.
Category:
News and Media
ICICI Prudential AMCs Rs 10,600 crore IPO drew nearly Rs 3 lakh crore in bids, led by strong global and domestic institutional demand. Robust anchor participation underscored confidence, though valuation and OFS structure suggest a steady, not explosive, listing.
Category:
News and Media
Critics say Bounce Back Loans were vulnerable to fraud, but Sunak cited need for speedy rollout
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||